Ken Coleman
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 7
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Anne-Marie Girard (2 shared papers)Christine Miossec (2 shared papers)Premavathy Levasseur (2 shared papers)John Pace (1 shared paper)David M. Shlaes (1 shared paper)Wright W. Nichols (1 shared paper)George L. Drusano (1 shared paper)Monica Borgonovi (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Nature Biotechnology (2 papers)Expert Opinion on Investigational Drugs (1 paper)Current Opinion in Microbiology (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Ken Coleman
12 papers receiving 438 citations
Peers
Comparison fields: 5 of 58
- Molecular Medicine 331
- Applied Microbiology and Biotechnology 91
- Pharmacology 245
- Endocrinology 35
- Epidemiology 151
Countries citing papers authored by Ken Coleman
This map shows the geographic impact of Ken Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Coleman more than expected).
Fields of papers citing papers by Ken Coleman
This network shows the impact of papers produced by Ken Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Coleman. The network helps show where Ken Coleman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 197 | |
| 2 | 2014 | 79 | |
| 3 | 2015 | 50 | |
| 4 | 1994 | 36 | |
| 5 | 2013 | 30 | |
| 6 | 2004 | 26 | |
| 7 | 1995 | 13 | |
| 8 | 2014 | 8 | |
| 9 | 2007 | 8 | |
| 10 | 2006 | 6 | |
| 11 | 1989 | 2 | |
| 12 | 1989 | 1 |
About Ken Coleman
Ken Coleman is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Molecular Biology and Pollution, having authored 12 papers that have together received 456 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmaceutical and Antibiotic Environmental Impacts (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Antibiotic Use and Resistance (2 papers), Animal Nutrition and Physiology (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper) and Antifungal resistance and susceptibility (1 paper). The work is most often cited by research in Molecular Medicine (331 citations), Applied Microbiology and Biotechnology (91 citations), Pharmacology (245 citations), Endocrinology (35 citations) and Epidemiology (151 citations). Ken Coleman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Anne-Marie Girard, Christine Miossec, Premavathy Levasseur, John Pace, David M. Shlaes, Wright W. Nichols, George L. Drusano, Monica Borgonovi, Henri Merdjan and Caroline Perry. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Nature Biotechnology, Expert Opinion on Investigational Drugs, Current Opinion in Microbiology and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.